Ophthalmology
77 FDA-approved drugs
Recent Approvals
TRYPTYR
ACOLTREMON
the signs and symptoms of dry eye disease...
2025-05-28
Novartis
PAVBLU
AFLIBERCEPT-AYYH
patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1...
2024-08-23
Amgen
VEGFVEGF-AVEGFR
AHZANTIVE
AFLIBERCEPT-MRBB
patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD) (1...
2024-06-28
FORMYCON AG
VIGAFYDE
VIGABATRIN
VIGAFYDE is indicated as monotherapy for the treatment of i nfantile spasms in pediatric patients 1 ...
2024-06-17
PYROS PHARMS
BYQLOVI
CLOBETASOL PROPIONATE
post-operative inflammation and pain following ocular surgery...
2024-03-04
HARROW EYE
FLUOROMETHOLONE
FLUOROMETHOLONE
corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior ...
2024-01-09
AMNEAL
EYLEA HD
AFLIBERCEPT
patients with: Neovascular (Wet) Age-Related Macular Degeneration (nAMD) ( 1...
2023-08-18
Regeneron
VEGFVEGF-AVEGFR
IZERVAY
AVACINCAPTAD PEGOL SODIUM
geographic atrophy (GA) secondary to age-related macular degeneration (AMD)...
2023-08-04
ASTELLAS
MIEBO
PERFLUOROHEXYLOCTANE
the signs and symptoms of dry eye disease (DED)...
2023-05-18
BAUSCH AND LOMB INC
SYFOVRE
PEGCETACOPLAN
geographic atrophy (GA) secondary to age-related macular degeneration (AMD)...
2023-02-17
APELLIS PHARMS
IHEEZO
CHLOROPROCAINE HYDROCHLORIDE
ocular surface anesthesia...
2022-09-27
HARROW EYE
CIMERLI
RANIBIZUMAB-EQRN
patients with: CIMERLI, a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the ...
2022-08-02
Novartis
VEGFVEGF-A
VABYSMO
FARICIMAB-SVOA
patients with: VABYSMO is a vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2) inh...
2022-01-28
Roche
VEGFVEGF-A
XIPERE
TRIAMCINOLONE ACETONIDE
macular edema associated with uveitis...
2021-10-22
BAUSCH AND LOMB INC
SUSVIMO
RANIBIZUMAB
patients with: Neovascular (wet) Age-related Macular Degeneration (AMD) who have previously responde...
2021-10-22
Roche
VEGFVEGF-A
TYRVAYA
VARENICLINE TARTRATE
the signs and symptoms of dry eye disease...
2021-10-15
OYSTER POINT PHARMA
BYOOVIZ
RANIBIZUMAB-NUNA
patients with: BYOOVIZ, a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the ...
2021-09-17
SAMSUNG BIOEPIS CO LTD
VEGFVEGF-A
BRONCHITOL
MANNITOL
the reduction of: • intracranial pressure and treatment of cerebral edema...
2020-10-30
PHARMAXIS EUROPE
EYSUVIS
LOTEPREDNOL ETABONATE
the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease...
2020-10-26
Novartis
BEOVU
brolucizumab-dbll
the treatment of: BEOVU is a human vascular endothelial growth factor (VEGF) inhibitor indicated for...
2019-10-07
Novartis
VEGFVEGF-AVEGFR
Showing 20 of 77 drugs
Top Companies
Drug Classes
Osmotic Diuretic 16
Vascular Endothelial Growth Factor Inhibitor 7
Corticosteroid 7
Carnitine Analog 4
Anti-epileptic Agent 1
Semifluorinated Alkane 1
Complement Inhibitor 1
Recombinant Human Nerve Growth Factor 1
Histamine-1 Receptor Antagonist 1
Lymphocyte Function-Associated Antigen-1 Antagonist 1
Quick Stats
- Total Drugs
- 77
- Companies
- 33
- Drug Classes
- 15
- Latest Approval
- 2025-05-28